ContraFect Corporation (CFRXQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
+0.0000 (900.00%)
At close: Dec 30, 2025
ContraFect Market Cap
ContraFect has a market cap or net worth of $107 as of January 23, 2026. Its market cap has decreased by -100.00% in one year.
Market Cap
107.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 15, 2014, ContraFect's market cap has decreased from 87.34M to 107.00, a decrease of -100.00%. That is a compound annual growth rate of -70.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 107.00 | 872.73% |
| Dec 26, 2024 | 11.00 | -100.00% |
| Dec 29, 2023 | 321.14K | -92.34% |
| Dec 30, 2022 | 4.19M | -95.95% |
| Dec 31, 2021 | 103.45M | -26.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Q BioMed | 145.00 |
| NexImmune | 139.00 |
| PsyBio Therapeutics | 133.00 |
| Marizyme | 132.00 |
| RVL Pharmaceuticals | 111.00 |
| Notable Labs | 97.00 |
| Infinity Pharmaceuticals | 91.00 |
| American Oriental Bioengineering | 88.00 |